PARCC Inserm
Partager
PARCC is a research institute dedicated to promote excellence in cardiovascular translational research.
10/01/2019
Alain Tedgui, Grand Prix Inserm 2018
12/12/2017
Bravo à l'équipe PL Tharaux pour leur publication dans Nature Communication sur le rôle du microARN-92 dans la glomérulonephrite !
Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis Crescentic rapidly progressive glomerulonephritis is a severe form of glomerula disease characterized by podocyte proliferation and migration. Here Henique et al. demonstrate that inhibition of miRNA-92a prevents kidney failure by promoting the expression of CDK inhibitor p57Kip2 that?...
Cliquez ici pour réclamer votre Listage Commercial.
Site Web
Adresse
56 Rue Leblanc
Paris
75015
